ECM
BHVN icon

ExodusPoint Capital Management’s Biohaven BHVN Stock Holding History

ExodusPoint Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7M Buy
1,501,099
+309,073
+26% +$3.38M 0.1% 183
2025
Q4 		$13.5M Buy
1,192,026
+1,025,168
+614% +$12.7M 0.11% 181
2025
Q3 		$2.5M Buy
166,858
+123,257
+283% +$1.79M 0.03% 658
2025
Q2 		$615K Buy
+43,601
New +$777K 0.01% 1096
2024
Q3 		– Sell
-57,903
Closed -$2.01M – 1632
2024
Q2 		$2.01M Buy
+57,903
New +$2.29M 0.01% 775

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's BHVN Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Biohaven (BHVN) stake by 26% in Q1 2026, buying an estimated $3.38M and bringing the position to 1,501,099 shares worth $12.7M. The position accounts for 0.1% of the portfolio, ranked #183.

ExodusPoint Capital Management first reported a position in BHVN in Q2 2024 and has held it in 5 quarters since. The position peaked at $13.5M in Q4 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • ExodusPoint Capital Management held 1,501,099 shares of Biohaven worth $12.7M as of Q1 2026.
  • ExodusPoint Capital Management bought 309,073 Biohaven shares in Q1 2026, an estimated $3.38M.
  • Biohaven made up 0.1% of ExodusPoint Capital Management's portfolio in Q1 2026, its #183 holding.
  • ExodusPoint Capital Management first reported a position in Biohaven in Q2 2024 and has held it in 5 quarters since.
  • ExodusPoint Capital Management's Biohaven position peaked at $13.5M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.